Skip to Content

Novifit M (Canada)

This page contains information on Novifit M for veterinary use.
The information provided typically includes the following:
  • Novifit M Indications
  • Warnings and cautions for Novifit M
  • Direction and dosage information for Novifit M

Novifit M

This treatment applies to the following species:
Manufacturer: Virbac

BEHAVIOR

NN.V4V2

NoviSAMe® Tablets

STIMULATE VITALITY

VETERINARY USE ONLY

HELPS SUPPORT COGNITIVE FUNCTION OF AGING DOGS.

KEEP OUT OF REACH OF CHILDREN.

NOVIFIT® Tablets are only available through a licensed veterinarian.

ACTIVE INGREDIENT (PER TABLET)

S-Adenosyl-L-Methionine-Tosylate Disulfate (NoviSAMe® Ingredient)

200 mg

Cautions: Consult a veterinarian before using in animals with liver disease, kidney disease or diabetes. Not for use in pregnant and lactating animals. Use caution when using any SAMe based products with SSRI drugs.

Recommended Use: Recommended for aging dogs to maintain normal levels of activity and awareness. NOVIFIT® M Tablets are a highly pure and stable form of SAMe (NoviSAMe® Ingredient) presented in an enteric-coated tablet. NOVIFIT M Tablets also support normal liver function.

Directions For Use

NOVIFIT Tablets should be administered at the first signs of behaviour problems related to aging. Give tablet after removing from foil pack. Tablets should not be split or crushed. Allow 60 days of use to see optimal results. NOVIFIT Tablets are intended for the lifetime of the patient. Consult your veterinarian for behavioural enrichment activities that may also help to improve the patient’s level of activity and awareness. It is not necessary to administer NOVIFIT Tablets on an empty stomach.

Size of Pet

Administration

Dogs: 10-19.9 kg

1 tablet once daily

May be used for the lifetime of the patient.

Warnings

For animal use only. Keep out of the reach of children and animals. In case of accidental overdose, contact a health professional immediately.

Storage

Store at 15-30° C. Store in cool dry place. Keep tablets in original foil pack until used. Tablets are sensitive to moisture and extreme heat and should not be split or crumbled.

QUESTIONS?

1-800-338-3659 • virbac.ca

Made in the Netherlands

Manufactured for Virbac AH, Inc., PO Box 162059, Fort Worth, TX 76161 USA

Distributed in Canada by: Virbac Canada, Inc., 1400-340 Albert Street, Ottawa, Ontario, K1R 0A5

Adverse reactions reporting and veterinary technical services questions: call 1-800-338-3659 or visit virbac.ca

NOVIFIT and NoviSAMe are registered trademarks of Virbac S.A. in Canada used under license by Virbac AH, Inc.

302205-01

Contains

 

 

30 enteric-coated tablets

10-20 kg

500759-01

NAC No.: 1177054.4

VIRBAC CANADA INC.
209-231 SHEARSON CRESCENT, CAMBRIDGE, ON, N1T 1J5
Toll-Free:   866-458-3350
Fax:   519-621-4114
Website:   www.virbac.ca
Email:   info@virbac.ca
Every effort has been made to ensure the accuracy of the Novifit M information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-10-31

Hide